| A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer RW Ahn, F Chen, H Chen, ST Stern, JD Clogston, AK Patri, MR Raja, ... Clinical cancer research 16 (14), 3607-3617, 2010 | 132 | 2010 |
| Structural and Mechanistic Basis of Zinc Regulation Across the E. coli Zur Regulon BA Gilston, S Wang, MD Marcus, MA Canalizo-Hernández, EP Swindell, ... PLoS biology 12 (11), e1001987, 2014 | 123 | 2014 |
| Anticancer activity of small-molecule and nanoparticulate arsenic (III) complexes EP Swindell, PL Hankins, H Chen, ĐU Miodragović, TV O’Halloran Inorganic chemistry 52 (21), 12292-12304, 2013 | 106 | 2013 |
| Arsenoplatin-1 is a dual pharmacophore anticancer agent Đ Miodragović, A Merlino, EP Swindell, A Bogachkov, RW Ahn, ... Journal of the American Chemical Society 141 (16), 6453-6457, 2019 | 50 | 2019 |
| The many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single target TV O'Halloran, R Ahn, P Hankins, E Swindell, AP Mazar Theranostics 3 (7), 496, 2013 | 50 | 2013 |
| Urokinase plasminogen activator system–targeted delivery of nanobins as a novel ovarian cancer therapy Y Zhang, HA Kenny, EP Swindell, AK Mitra, PL Hankins, RW Ahn, K Gwin, ... Molecular cancer therapeutics 12 (12), 2628-2639, 2013 | 39 | 2013 |
| 3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation P Sethi, A Jyoti, EP Swindell, R Chan, UW Langner, JM Feddock, ... Nanomedicine: Nanotechnology, Biology and Medicine 11 (8), 2013-2023, 2015 | 32 | 2015 |
| Direct binding of arsenic trioxide to AMPK and generation of inhibitory effects on acute myeloid leukemia precursors EM Beauchamp, EM Kosciuczuk, R Serrano, D Nanavati, EP Swindell, ... Molecular cancer therapeutics 14 (1), 202-212, 2015 | 31 | 2015 |
| Beyond cisplatin: Combination therapy with arsenic trioxide Ð Miodragović, EP Swindell, ZS Waxali, A Bogachkov, TV O'Halloran Inorganica chimica acta 496, 119030, 2019 | 29 | 2019 |
| Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer M Upreti, A Jyoti, SE Johnson, EP Swindell, D Napier, P Sethi, R Chan, ... Oncotarget 7 (27), 41559, 2016 | 18 | 2016 |
| Improved anti-proliferative effect of doxorubicin-containing polymer nanoparticles upon surface modification with cationic groups SA Krovi, EP Swindell, TV O'Halloran, SBT Nguyen Journal of materials chemistry 22 (48), 25463-25470, 2012 | 17 | 2012 |
| pH-Responsive Theranostic Polymer-Caged Nanobins (PCNs): Enhanced Cytotoxicity and T1 MRI Contrast by Her2-Targeting BJ Hong, EP Swindell, KW MacRenaris, PL Hankins, AJ Chipre, ... Particle & particle systems characterization: measurement and description of …, 2013 | 14 | 2013 |
| Targeting EphA2 in bladder cancer using a novel antibody-directed nanotherapeutic W Kamoun, E Swindell, C Pien, L Luus, J Cain, M Pham, I Kandela, ... Pharmaceutics 12 (10), 996, 2020 | 8 | 2020 |
| Liposomes containing piperazine compounds inhibit tumor growth in a patient-derived xenograft model of glioblastoma multiforme EP Swindell, A Ugolkov, C Freguia, O Dubrovskyi, PL Hankins, J Yang, ... Cancer Research 75 (15_Supplement), 4389-4389, 2015 | 3 | 2015 |
| Activity of Nanobins Loaded with Cisplatin and Arsenic Trioxide in Primary and Metastatic Breast Cancer EP Swindell III Northwestern University, 2015 | 2 | 2015 |
| Targeting EphA2 in bladder cancer using a novel antibody-directed nanotherapeutic W Kamoun, E Swindell, C Pien, L Luus, J Cain, I Kandela, R Huang, ... Cancer Research 78 (13_Supplement), 5771-5771, 2018 | 1 | 2018 |
| Targeted delivery of doxorubicin loaded nanobins to ovarian cancer cells through the urokinase plasminogen activator system Y Zhang, EP Swindell, PL Hankins, HA Kenny, TV O'Halloran, AP Mazar, ... CLINICAL CANCER RESEARCH 21, 2015 | | 2015 |
| Abstract POSTER-THER-1440: Targeted delivery of doxorubicin loaded nanobins to ovarian cancer cells through the urokinase plasminogen activator system Y Zhang, EP Swindell, PL Hankins, HA Kenny, TV O'Halloran, AP Mazar, ... Clinical Cancer Research 21 (16_Supplement), POSTER-THER-1440-POSTER-THER-1440, 2015 | | 2015 |
| Impact of tumor microenvironment on tumor growth, metastasis and response to combination therapy via microenvironment-responsive dual drug-loaded nanoparticles and radiation P Sethi, A Jyoti, E Swindell, UW Langner, WHS Clair, RC McGarry, ... Cancer Research 74 (19_Supplement), 4589-4589, 2014 | | 2014 |
| A novel strategy for targeted drug delivery to the tumor vasculature by radiation-induced receptor expression on endothelial cells M Upreti, A Jamshidi-Parsian, E Swindell, S Apana, MC Berridge, ... Cancer Research 72 (8_Supplement), 4644-4644, 2012 | | 2012 |
Thomas O'HalloranNorthwestern UniversityVerified email at northwestern.edu
